Dr. Yu Qi

Cardiothoracic Surgery

MD, Vice Director of Thoracic Surgery, Professor of Thoracic, Surgery, The First Affiliated Hospital of Zhengzhou University, China

China

Publications Featured in

Publications

Selected publications from PubMed

Corrigendum to "DPEP1 mediates regulation of mitochondrial quality control via FOXO1/ALDH1L2 axis to attenuate ferroptosis in pulmonary endothelial cells to alleviate sepsis-associated acute lung injury" [Int. Immunopharmacol. 170 (2026) 116049].

Yao X, Wen Z, Liao J, Meng Y, Lu P, Li X, Shen Z, Wang A, Wu M, Li X, Jin W, Zhang X, Qi Y, Feng J, Chu M, Zhang J, Dai Y, Qin X, Zhan F, Wang X, Song M

Int Immunopharmacol. 2026 Jun 1;178:116552 doi: 10.1016/j.intimp.2026.116552.

DPEP1 mediates regulation of mitochondrial quality control via FOXO1/ALDH1L2 axis to attenuate ferroptosis in pulmonary endothelial cells to alleviate sepsis-associated acute lung injury.

Yao X, Wen Z, Liao J, Meng Y, Lu P, Li X, Shen Z, Wang A, Wu M, Li X, Jin W, Zhang X, Qi Y, Feng J, Chu M, Zhang J, Dai Y, Qin X, Zhan F, Wang X, Song M

Int Immunopharmacol. 2026 Feb 1;170:116049 doi: 10.1016/j.intimp.2025.116049.

FABP4-mediated lipid droplet accumulation drives epithelial-mesenchymal transition and aggravates alveolar epithelial barrier disruption.

Shen Z, Qi Y, Chu M, Wu M, Feng C, Li X, Liu Z, Si L, Wang Y, Zhang J, Lu X, Lu P

Clin Transl Med. 2026 Jan;16(1):e70563 doi: 10.1002/ctm2.70563.

Genome-wide CRISPR screen reveals an uncharacterized spliceosome regulator as new candidate immunotherapy target.

Shao T, Liu C, Kuang J, Xie S, Qu Y, Li Y, Zhang L, Liu F, Qi Y, Hou T, Li M, Zhang S, Liu Y, Yuan Z, Liu J, Hu Y, Wang J, Song C, Zhang S, Zhu L, Shao J, Lin A, Mao W, Wang G, Zhu L

Imeta. 2025 Dec;4(6):e70096 doi: 10.1002/imt2.70096.

N-terminal pro-brain natriuretic peptide as a predictor of postoperative atrial fibrillation in off-pump coronary artery bypass grafting patients.

Li X, Shen Z, Qi Y, Chu M, Wu M, Feng C, Liu Z, Wang Y, Zhang J, Lu X, Lu P

BMC Cardiovasc Disord. 2025 Oct 21;25(1):754 doi: 10.1186/s12872-025-05203-8.

Featured in

1h 28min

Evolving Surgical Approaches for Challenging Thoracic Tumors

Since the late 20th century, Chinese medicine has developed rapidly in comparison to the rest of the world, being China one of the countries which have made more significant advances in medical research and treatments. Aiming to provide a comprehensive, in-depth look at how Chinese medicine is practiced and examine its impact on global health, we are proud to introduce Meet the Masters, as part of the Healing in China series, which brings together the best Chinese KOLs and top surgeons from other regions of the world to guide you through their surgeries and transfer years of knowledge. In this event, AIS Channel specially invites top thoracic surgery experts from China and the United States to share academic insights on evolving surgical approaches for challenging thoracic tumors. This event features operation videos, case sharing, and interactive discussions to enhance surgical skills and improve global standards in this field.

With Johnson & Johnson MedTech

Published

Aug 2023

Share this expert

Help your network discover Dr. Yu Qi's clinical expertise.